Baglin T - Search Results

1

Guidelines on the use and monitoring of heparin.

Baglin T, Barrowcliffe TW, Cohen A, Greaves M; British Committee for Standards in Haematology. Baglin T, et al. Br J Haematol. 2006 Apr;133(1):19-34. doi: 10.1111/j.1365-2141.2005.05953.x. Br J Haematol. 2006. PMID: 16512825 No abstract available.

2

Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures.

Veitch AM, Baglin TP, Gershlick AH, Harnden SM, Tighe R, Cairns S; British Society of Gastroenterology; British Committee for Standards in Haematology; British Cardiovascular Intervention Society. Veitch AM, et al. Among authors: baglin tp. Gut. 2008 Sep;57(9):1322-9. doi: 10.1136/gut.2007.142497. Epub 2008 May 9. Gut. 2008. PMID: 18469092 Review. No abstract available.

3

Discovery and characterization of an antibody directed against exosite I of thrombin.

Baglin TP, Langdown J, Frasson R, Huntington JA. Baglin TP, et al. J Thromb Haemost. 2016 Jan;14(1):137-42. doi: 10.1111/jth.13171. Epub 2015 Dec 29. J Thromb Haemost. 2016. PMID: 26469093 Free article.

4

The risk of a first and a recurrent venous thrombosis associated with an elevated D-dimer level and an elevated thrombin potential: results of the THE-VTE study.

van Hylckama Vlieg A, Baglin CA, Luddington R, MacDonald S, Rosendaal FR, Baglin TP. van Hylckama Vlieg A, et al. Among authors: baglin tp, baglin ca. J Thromb Haemost. 2015 Sep;13(9):1642-52. doi: 10.1111/jth.13043. Epub 2015 Aug 27. J Thromb Haemost. 2015. PMID: 26178257 Free article.

5

Venous thrombosis.

Wolberg AS, Rosendaal FR, Weitz JI, Jaffer IH, Agnelli G, Baglin T, Mackman N. Wolberg AS, et al. Among authors: baglin t. Nat Rev Dis Primers. 2015 May 7;1:15006. doi: 10.1038/nrdp.2015.6. Nat Rev Dis Primers. 2015. PMID: 27189130 Review.

6

Inherited and acquired risk factors for venous thromboembolism.

Baglin T. Baglin T. Semin Respir Crit Care Med. 2012 Apr;33(2):127-37. doi: 10.1055/s-0032-1311791. Epub 2012 May 30. Semin Respir Crit Care Med. 2012. PMID: 22648484

7

Combined factor IIa and Xa inhibitor therapy for thrombosis whilst on therapeutic anticoagulant.

Arachchillage DR, Besser M, Maclean R, Baglin T, van Veen JJ. Arachchillage DR, et al. Among authors: baglin t. Thromb Res. 2016 Jul;143:137-40. doi: 10.1016/j.thromres.2016.05.007. Epub 2016 May 11. Thromb Res. 2016. PMID: 27244105 No abstract available.

8

Analysis of pulmonary embolus size at the time of recurrence compared with presentation: a single-centre retrospective study.

Thomas W, Firth O, Besser M, Beveridge M, Baglin T. Thomas W, et al. Among authors: baglin t. J Thromb Haemost. 2017 Jul;15(7):1443-1447. doi: 10.1111/jth.13703. Epub 2017 May 24. J Thromb Haemost. 2017. PMID: 28430391 Free article.

9

Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH.

Baglin T, Bauer K, Douketis J, Buller H, Srivastava A, Johnson G; SSC of the ISTH. Baglin T, et al. J Thromb Haemost. 2012 Apr;10(4):698-702. doi: 10.1111/j.1538-7836.2012.04662.x. J Thromb Haemost. 2012. PMID: 22332937 Free article. No abstract available.

10

Unprovoked deep vein thrombosis should be treated with long-term anticoagulation--no.

Baglin T. Baglin T. J Thromb Haemost. 2007 Dec;5(12):2336-9. doi: 10.1111/j.1538-7836.2007.02771.x. Epub 2007 Sep 24. J Thromb Haemost. 2007. PMID: 17892533 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results